SK Capital Acquires Catalent's Blow‑Fill‑Seal Sterile CDMO Business (Woodstock Sterile Solutions)
March 31, 2021
Funds managed by SK Capital Partners completed the acquisition of Catalent Pharma Solutions' Blow‑Fill‑Seal (BFS) sterile CDMO business and relaunched the business as Woodstock Sterile Solutions. The single‑site Woodstock, Illinois operation will operate independently under new CEO Paul Josephs, supporting global pharmaceutical and biologics customers; Catalent was the seller and debt financing was provided by Cerberus Business Finance.
- Buyers
- SK Capital Partners
- Targets
- Woodstock Sterile Solutions
- Sellers
- Catalent Pharma Solutions
- Industry
- Pharmaceuticals
- Location
- Illinois, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Sharp Acquires Berkshire Sterile Manufacturing
October 5, 2023
Healthcare Services
Sharp has acquired Berkshire Sterile Manufacturing (BSM), a Lee, Massachusetts-based fill-finish CDMO specializing in sterile injectable products. The deal adds small-to-medium scale sterile injectable manufacturing (including isolator-based filling and lyophilization) to Sharp’s clinical supply, packaging and distribution capabilities and brings BSM’s ~228 employees into the Sharp organization.
-
Sole Source Capital Acquires Westwood Laboratories
October 17, 2022
Manufacturing
Sole Source Capital LLC, an industrial-focused private equity firm, has acquired Westwood Laboratories, a full-service contract manufacturer headquartered in Azusa, California that serves beauty, personal care, pet and over-the-counter drug brands. Five Points Capital provided unitranche debt and an equity co-invest to support the acquisition; terms were not disclosed.
-
SK pharmteco Acquires Controlling Interest in Center for Breakthrough Medicines
September 19, 2023
Biotechnology
SK pharmteco is acquiring a controlling interest in cell and gene therapy CDMO Center for Breakthrough Medicines (CBM), integrating CBM with its Paris-based Yposkesi to create a global cell & gene therapy business unit. The deal expands SK pharmteco's technical capabilities, production capacity, and U.S./European footprint in advanced biologics manufacturing.
-
GHO Capital Acquires Majority Stake in Sterling Pharma Solutions
February 28, 2019
Pharmaceuticals
GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.
-
SK Capital Acquires Baker Hughes Specialty Polymers Business (NuCera Solutions)
July 27, 2020
Manufacturing
Funds advised by SK Capital Partners agreed to acquire the specialty polymers business from Baker Hughes and completed the carveout in October 2020, rebranding the business as NuCera Solutions. SK Capital said it will operate the business as an independent specialty polymers manufacturer with a focus on product innovation and operational improvement, with manufacturing operations in Barnsdall, Oklahoma.
-
Blue Wolf Capital Acquires Seven Recipharm OSD Sites and Agrees to Buy Synerlab to Create New CDMO Platform
April 2, 2024
Pharmaceuticals
Blue Wolf Capital Partners has agreed to acquire seven oral solid dosage (OSD) manufacturing and development facilities from Recipharm (located in Sweden, France and Spain) and has also agreed, subject to regulatory approvals, to acquire Synerlab, a Strasbourg-based CDMO. The transactions are intended to form a new independent CDMO platform (headquartered in the UK) that expands Blue Wolf's pharmaceutical manufacturing capabilities and commercial reach across Europe.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.